{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:44:33Z","timestamp":1767134673324,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":19,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001415","type":"reference-entry","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T22:16:04Z","timestamp":1069366564000},"source":"Crossref","is-referenced-by-count":19,"title":["Gabapentin add-on for drug-resistant partial epilepsy"],"prefix":"10.1002","author":[{"given":"Anthony G","family":"Marson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria Z","family":"Kadir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane L","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1999,1,25]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD001415-BIB1|cit1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1528-1157.1994.tb02513.x","article-title":"Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study","volume":"35","author":"Anhut","journal-title":"Epilepsia"},{"issue":"8","key":"10.1002\/14651858.CD001415-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1528-1157.1999.tb00833.x","article-title":"Gabapentin as add-on therapy in children with refractory partial seizures: a 12 week , multicentre, double blind placebo controlled study","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD001415-BIB3|cit3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1157.1991.tb04689.x","article-title":"Double blind study of gabapentin in the treatment of partial seizures","volume":"32","author":"Sivenius","year":"1991","journal-title":"Epilepsia"},{"issue":"8698","key":"10.1002\/14651858.CD001415-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0140-6736(90)91123-R","article-title":"Gabapentin in partial epilepsy","volume":"335","year":"1990","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD001415-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1212\/WNL.43.11.2292","article-title":"Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study","volume":"43","year":"1993","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001415-BIB6|cit6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/jnnp.50.6.682","article-title":"Gabapentin as an antiepileptic drug in man","volume":"50","author":"Crawford","year":"1987","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001415-BIB7|cit7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.62.4.372","article-title":"Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy","volume":"62","author":"Leach","year":"1997","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Suppl Florence","key":"10.1002\/14651858.CD001415-BIB8|cit8","first-page":"69","article-title":"A double blind study of gabapentin in partial seizures","volume":"41","author":"Kwan","year":"2000","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001415-BIB9|cit9","first-page":"151","article-title":"Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy","volume":"56","author":"Tomovic","year":"1999","journal-title":"Vojnosanit-Pregl"},{"issue":"4","key":"10.1002\/14651858.CD001415-BIB10|cit10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1819.2006.01553.x","article-title":"Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study","volume":"60","author":"Yamauchi","year":"2006","journal-title":"Psychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD001415-BIB11|cit11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the national general practice study of epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001415-BIB12|cit12","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"Effron","year":"1993"},{"key":"10.1002\/14651858.CD001415-BIB13|cit13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in Rochester, Minisota 1935 through 1984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD001415-BIB14|cit14","article-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.4 [updated March 2005]","author":"Higgins","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001415-BIB15|cit15","first-page":"72","article-title":"Gabapentin","volume":"36 Suppl","author":"McClean","year":"1995","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415-BIB16|cit16","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"McCullagh","year":"1989"},{"key":"10.1002\/14651858.CD001415-BIB17|cit17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1528-1157.1981.tb06158.x","article-title":"Phenytoin for epilepsy: a long term prospective study, assisted by serum level monitoring in previoulsy untreated patients","volume":"22","author":"Reynolds","year":"1981","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD001415-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/bmj.313.7066.1169","article-title":"New antiepileptic drugs: a systematic review of their efficacy and tolerability","volume":"313","author":"Marson","year":"1996","journal-title":"British Medicial Journal"},{"key":"10.1002\/14651858.CD001415-BIB19|cit19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1528-1157.1997.tb01251.x","article-title":"The new antiepilaptic drugs: a systematic review of their efficacy and tolerability","volume":"38","author":"Marson","year":"1997","journal-title":"Epilepsia"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001415.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:02:45Z","timestamp":1628528565000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001415"}},"subtitle":[],"editor":[{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[1999,1,25]]},"references-count":19,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001415","relation":{},"subject":[],"published":{"date-parts":[[1999,1,25]]}}}